Small
Normal
Large
HOME
> News Releases
2012
2011
2010
2009
2008
2007
2006
2005
2004
Dainippon Pharmaceutical
Sumitomo Pharmaceuticals
Finances
Products
R&D
CSR
Licensing
Corporate
Related Business
Others
2012.05.10
PDF/383KB
Supplementary Financial Data for the Year Ended March 31, 2012
2012.05.10
PDF/349KB
Summary of Consolidated Financial Results for the Year Ended March 31, 2012 (Unaudited)
2012.05.10
PDF/46KB
Change of Members of Board of Directors and Executive Officer
2012.05.10
PDF/113KB
New Study Shows Patients Can Effectively be Switched to Latuda (lurasidone HCl) from Other Antipsychotic Agents
2012.05.08
PDF/93KB
SUNOVION ANNOUNCES UPCOMING AVAILABILITY OF ZETONNA (ciclesonide) NASAL AEROSOL, A NON-AQUEOUS, DRY NASAL AEROSOL SPRAY FOR ALLERGIC RHINITIS
2012.05.07
PDF/118KB
Dainippon Sumitomo Pharma Co. Reports that Latuda (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression (Updated version)
More News Releases
2012
2011
2010
2009
2008
2007
2006
2005
2004
Dainippon Pharmaceutical
Sumitomo Pharmaceuticals